Here's the Anti-Enron


Motley Fool financial analyst Matt Koppenheffer sat down for brunch on Sunday with the management team at Markel , and in this video, he discusses with Fool financial analyst David Hanson some of his takeaways from the day. Particularly, he focuses on Markel CEO Tom Gayner's statement that they don't like having people at the company who want to be stars. Matt and David discuss the idea of "The Talent Myth," and compare Markel in this sense to the former Enron.

Markel is often called "The Baby Berkshire" for having such a similar business model to the investing giant. Thanks to the savvy of investing legend Warren Buffett, Berkshire Hathaway's book value per share has grown a mind-blowing 586,817% over the past 48 years. But with Buffett aging and Berkshire rapidly evolving, is this insurance conglomerate still a buy today? In The Motley Fool's premium report on the company, Berkshire expert Joe Magyer provides investors with key reasons to buy as well as important risks to watch out for. Click here now for instant access to Joe's take on Berkshire!

The article Here's the Anti-Enron originally appeared on

David Hanson owns shares of Markel. Matt Koppenheffer owns shares of Berkshire Hathaway and Markel. The Motley Fool recommends and owns shares of Berkshire Hathaway and Markel. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.